AD Article
Will the Court of Justice Spell the End of the French Strict Liability Regime?
In the case No C-473/22 between Mylan and Gilead, the Advocate General analysed the Finnish strict liability regime primarily in the light of the lessons a
A head start
Deep knowledge of your sectors and ecosystems
Your strategic issues, our expertise
Contact
François Pochart joined August Debouzy in 2011, after more than 15 years as a patent attorney. Together with Grégoire Desrousseaux and Lionel Martin, he leads a team of engineers and lawyers specialized in patent law. He assists French and foreign clients in all matters relating to patents:
François is one of France's leading players in patent litigation concerning life sciences, pharmaceuticals and medical devices. His diversified experience (small molecules, biologics, formulas, medical devices, secondary therapeutic applications, etc.), combined with an in-depth knowledge of drug and medical device regulations and close collaboration with August Debouzy's Public and Regulatory team, enables him and his team to handle the most complex matters with great efficiency, particularly on regulatory issues and questions relating to supplementary protection certificates (SPCs).
He contributes to the transmission of knowledge by lecturing on patent law to professional associations, training organizations and universities (including Politecnico di Milano, C5, Life Science Patent Network, MIP). Convinced that sharing experience stimulates individual and collective talent, François and his team also organize patent workshops for their clients.
French I English I Germain
AD Article
Will the Court of Justice Spell the End of the French Strict Liability Regime?
In the case No C-473/22 between Mylan and Gilead, the Advocate General analysed the Finnish strict liability regime primarily in the light of the lessons a
AD Article
The European Commission publishes proposals for a new pharmaceutical package
Le 26 avril 2023, la Commission européenne (CE) a publié un ensemble de propositions1 visant à modifier la législation dans le domaine pharmaceutique afin
AD Article
Spring-summer 2024: priority to the Olympics Games at the 3rd chamber of the Paris Court of 1st instance ?
The 3rd chamber of the Judicial Court of Paris is considering an organization dedicated to the litigation of the Olympic Games, between mid-May and Septemb
AD Article
E-filing of French patent applications: French PTO (INPI) shuffle its feet after messing with PLT
August & Debouzy wins its proceedings for exceeding its power (ultra vires) before the Conseil d'Etat against the decision of the Director of the
AD Deal
August Debouzy advises Cameco on French law aspects of acquisition of Westinghouse Electric Company
August Debouzy, in coordination with Covington & Burling, is advising Cameco Corporation, the world’s largest publicly traded uranium company and a cornerstone of the Canadian nuclear industry, on the French aspects of a contemplated acquisition of Westinghouse Electric Company, one of the world’s largest nuclear services businesses, for an enterprise value of $7.875 billion and an estimated $4.5 billion equity cost. Covington & Burling assisted Cameco with the general coordination of the transaction and the US law aspects.
AD Article
19th version of the UPC Rules of Procedure: the opt-out becomes more complex with the possibility of its removal
After the opt-out and the correction of the opt-out, there is now the addition of... the removal of the opt-out. Abstract: The 19th version of the Rules
AD Article
The WTO decision on the "lifting" of patents on Covid vaccines, in 6 questions
A decisive step has just been taken in the process of "lifting" the patents on vaccines against COVID-19, on which we have been publishing regularly since
AD Article
Preliminary Injunction on the basis of a Patent Application – Another French Oddity?
In an interim order dated 3 June 2022, the President of the Paris Judicial Court: • Ruled that a motion for interim injunction based on Article
AD Article
Opposition before the INPI: publication of the first opposition decision
In our article of 2 March 2022, we reported our impressions on the firsts oral proceedings before the INPI[1] and pointed out that they are very similar to
AD Deal
August Debouzy advised the Swiss group Holcim on the acquisition of the PRB group
August Debouzy, and in particular its German Desk, advised the Swiss group Holcim, a major player in innovative and sustainable construction solutions, on the acquisition of 100% of the PRB group, the leading independent French company in its sector offering a wide range of high-performance products for the renovation and thermal insulation of buildings.
More
Publications